Author

Narendra D. Lalwani

Observed names: N D Lalwani, N. D. LALWANI, N. D. Lalwani, N. Lalwani, N.D. Lalwani, NARENDRA D. LALWANI, Narendra D Lalwani, Narendra Lalwani

Institution: Esperion Therapeutics (United States)

Observed institutions: Northwestern University, Argonne National Laboratory, Shinshu University, Pfizer (United States), Baylor College of Medicine, Virginia Commonwealth University, University of Milan, Esperion Therapeutics (United States), Tata Memorial Hospital, Duke Medical Center, Cerenis Therapeutics (France), Louisville Metabolic and Atherosclerosis Research Center, Alchem Laboratories (United States), Northwestern Medicine, Imperial College London, Virginia Commonwealth University Medical Center

OpenAlex ID: A5113593298

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol

2019 · Kausik K. Ray, Harold E. Bays, et al. · New England Journal of Medicine · 838

PDF

Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis

2016 · Stephen L. Pinkosky, Roger S. Newton, et al. · Nature Communications · 508

PDF

Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease

2019 · Anne C. Goldberg, Lawrence A. Leiter, et al. · JAMA · 493

PDF

Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.

1986 · J K Reddy, S K Goel, et al. · Proceedings of the National Academy of Sciences · 324

Hepatic and Renal Effects of Peroxisome Proliferators: Biological Implications*

1982 · Janardan K. Reddy, John R. Warren, et al. · Annals of the New York Academy of Sciences · 233

Fas ligation triggers apoptosis in macrophages but not endothelial cells

1994 · Bruce C. Richardson, Narendra D. Lalwani, et al. · European Journal of Immunology · 184

PDF

Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators.

1982 · J K Reddy, N D Lalwani, et al. · PubMed · 178

Evaluation of Selected Hypolipidemic Agents for the Induction of Peroxisomal Enzymes and Peroxisome Proliferation in the Rat Liver

1983 · Narendra D. Lalwani, M. Kumudavalli Reddy, et al. · Human Toxicology · 136

Induction of hepatic peroxisome proliferation in nonrodent species, including primates.

1984 · J K Reddy, N D Lalwani, et al. · PubMed · 134

Peroxisome proliferation and lipid peroxidation in rat liver.

1986 · S K Goel, N D Lalwani, et al. · PubMed · 131

Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy

2016 · Christie M. Ballantyne, James M. McKenney, et al. · The American Journal of Cardiology · 119

PDF

Targeting ATP-Citrate Lyase in Hyperlipidemia and Metabolic Disorders

2017 · Stephen L. Pinkosky, Pieter H.E. Groot, et al. · Trends in Molecular Medicine · 118

Detection of a nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds

1983 · Narendra D. Lalwani, William E. Fahl, et al. · Biochemical and Biophysical Research Communications · 117

Induction and origin of hepatocytes in rat pancreas.

1984 · J K Reddy, M S Rao, et al. · The Journal of Cell Biology · 115

PDF

CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice

2013 · Claudine Tardy, Marine Goffinet, et al. · Atherosclerosis · 113

PDF

Phthalate Esters as Peroxisome Proliferator Carcinogens

1982 · J R Warren, N D Lalwani, et al. · Environmental Health Perspectives · 113

PDF

1984 · W E Fahl, N D Lalwani, et al. · Proceedings of the National Academy of Sciences · 112

Development of hepatocellular carcinomas and increased peroxisomal fatty acid β-oxidation in rats fed [4-chloro-6-(2, 3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14, 643) in the semipurified diet

1981 · Narendra D. Lalwani, M. Kumudavalli Reddy, et al. · Carcinogenesis · 101

Peroxisome proliferator-binding protein: identification and partial characterization of nafenopin-, clofibric acid-, and ciprofibrate-binding proteins from rat liver.

1987 · N D Lalwani, K Alvares, et al. · Proceedings of the National Academy of Sciences · 95

PDF

The absence of γglutamyl transpeptidase activity in putative preneoplastic lesions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator Wy-14,643

1982 · M.Sambasiva Rao, Narendra D. Lalwani, et al. · Carcinogenesis · 86

Induction, immunochemical identity and immunofluorescence localization of an 80000-molecular-weight peroxisome-proliferation-associated polypeptide (polypeptide PPA-80) and peroxisomal enoyl-CoA hydratase of mouse liver and renal cortex

1981 · Narendra D. Lalwani, M. Kumudavalli Reddy, et al. · Biochemical Journal · 77

Effects of inositol hexaphosphate on growth and differentiation in K-562 erythroleukemia cell line

1992 · Abulkalam M. Shamsuddin, Abdul Baten, et al. · Cancer Letters · 76

Comparison of Hepatic Peroxisome Proliferative Effect and Its Implication for Hepatocarcinogenicity of Phthalate Esters, Di(2-Ethylhexyl) Phthalate, and Di(2-Ethylhexyl) Adipate with a Hypolipidemic Drug

1986 · J K Reddy, M K Reddy, et al. · Environmental Health Perspectives · 75

Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial

2021 · John Rubino, Diane E. MacDougall, et al. · Journal of clinical lipidology · 74

PDF

Complementary low-density lipoprotein-cholesterol lowering and pharmacokinetics of adding bempedoic acid (ETC-1002) to high-dose atorvastatin background therapy in hypercholesterolemic patients: A randomized placebo-controlled trial

2019 · Narendra D. Lalwani, Jeffrey C. Hanselman, et al. · Journal of clinical lipidology · 73

Works count: 69

Citation count: 5,323

H-index: 31

I10-index: 51